US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
HB

HBMN.SW

Stock HBM Healthcare Investments AG
$234.00

SIX Swiss Exchange · Financial Services · CH

Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-08-28
HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

HBM Healthcare Investments AG (HBMN.SW) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$280.00
+19.7% · 1 analysts
Institutional own.
10.5%
of shares
COMPLIANT
Sharia compliance
<0.01%
Non-permissible income — HTR, from filings (2026-03-31)
$280.00
Price target (+19.7%) · 1 analysts
10.5%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-03-31. HBMN.SW files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 6.65% 30.00% Pass
Interest-bearing investments 0.36% 30.00% Pass
Non-permissible income 0.00% 5.00% Pass

Usmani Unverified

RatioValueThresholdResult
Interest-bearing debt 5.12% 33.00% Pass
Interest-bearing investments 0.28% 33.00% Pass
Non-liquid assets 99.72% at least 20.00% Pass
Non-permissible income 0.00% 5.00% Pass

MSCI Unverified

RatioValueThresholdResult
Interest-bearing debt 5.12% 33.33% Pass
Cash + interest-bearing securities 0.28% 33.33% Pass
Non-permissible income 0.00% 5.00% Pass

FTSE Unverified

RatioValueThresholdResult
Interest-bearing debt 5.12% 33.33% Pass
Cash + interest-bearing securities 0.28% 33.33% Pass
Non-permissible income 0.00% 5.00% Pass

Dow Jones Islamic Market Unverified

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 7.94% 33.00% Pass
Cash + interest-bearing securities 0.43% 33.00% Pass
Non-permissible income 0.00% 5.00% Pass

S&P Shariah Unverified

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 8.35% 33.00% Pass
Cash + interest-bearing securities 0.45% 49.00% Pass
Non-permissible income 0.00% 5.00% Pass

MSCI M-Series Unverified

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 8.35% 33.33% Pass
Cash + interest-bearing securities 0.45% 33.33% Pass
Non-permissible income 0.00% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

255.50232.87210.24187.61164.992025-09-122026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
228.83
S2
230.17
S1
232.83
PIVOT
234.17
R1
236.83
R2
238.17
R3
240.83

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
219.31 243.69
±5.27% from 231.50, made 2026-09-03 · resolves 2026-09-10
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22553 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSTRONG SELL
0 buy · 4 neutral · 3 sell
Moving averagesSTRONG SELL
3 buy · 0 neutral · 9 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)40.10NEUTRAL
Stochastic %K (14)43.75NEUTRAL
CCI (20)-40.72NEUTRAL
Williams %R (14)-56.25NEUTRAL
MACD (12,26,9)-0.00SELL
ROC (10)-0.43SELL
Momentum (10)-1.00SELL
EMA (10)234.62SELL
SMA (10)233.60BUY
EMA (20)237.30SELL
SMA (20)237.80SELL
EMA (30)239.08SELL
SMA (30)241.95SELL
EMA (50)239.70SELL
SMA (50)245.06SELL
EMA (100)235.17SELL
SMA (100)236.25SELL
EMA (200)223.32BUY
SMA (200)225.15BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About HBM Healthcare Investments AG

Financial Services · Asset Management

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

hbmhealthcare.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.